IP Verse

Immatics Biotechnologies competitive analysis

Loading summary...

Latest patents of Immatics Biotechnologies opposed by its competitors

Explore Immatics Biotechnologies's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3980776
Aug 28, 2024Sorting With Counter Selection Using Sequence Similar Peptides1
EP3236985
Sep 7, 2022Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (Hcc) And Other Cancers1

Latest publications and patents of Immatics Biotechnologies New

Explore the latest publications and patents granted to Immatics Biotechnologies, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Immatics Biotechnologies

EP3980776
Aug 28, 2024Sorting With Counter Selection Using Sequence Similar PeptidesGranted And Under Opposition
EP3236985
Sep 7, 2022Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (Hcc) And Other CancersPatent Maintained As Amended

Latest PTAB cases involving Immatics Biotechnologies

Discover the latest PTAB cases involving Immatics Biotechnologies, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Immatics Biotechnologies with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
IMMATICS BIOTECHNOLOGIES - 2 - -
ADAPTIMMUNE110 - -
STRAWMAN336 - - -